Organ Dysfunction Clinical Trials

12 recruitingLast updated: May 13, 2026

There are 12 actively recruiting organ dysfunction clinical trials across 9 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Moscow, Russia, San Francisco, California, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Organ Dysfunction Trials at a Glance

12 actively recruiting trials for organ dysfunction are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Moscow, San Francisco, and Houston. Lead sponsors running organ dysfunction studies include Petrovsky National Research Centre of Surgery, Dong Zhang, and Daniela Vasquez.

Browse organ dysfunction trials by phase

Treatments under study

About Organ Dysfunction Clinical Trials

Looking for clinical trials for Organ Dysfunction? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Organ Dysfunction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Organ Dysfunction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Validation of SOFA-2 for Mortality and Sepsis-3 Prevalence in Turkey

SepsisSeptic ShockCritical Illness+1 more
Marmara University2,500 enrolled1 locationNCT07300306
Recruiting

Organ Dysfunction Score for Obstetric Patients

SepsisPregnancyPostpartum+2 more
Daniela Vasquez130 enrolled18 locationsNCT07068022
Recruiting
Not Applicable

Efferon LPS Hemoadsorption in Cardiac Surgery Patients

Cardiac DiseaseMultiple Organ Dysfunction Syndrome
Efferon JSC60 enrolled3 locationsNCT07532174
Recruiting
Phase 2Phase 3

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Nationwide Children's Hospital500 enrolled32 locationsNCT05267821
Recruiting

Role of Transposable Elements in Septic Immune Aging

SepsisSepsis, Septic ShockSepsis and septic shock+5 more
University of California, San Francisco116 enrolled1 locationNCT06809868
Recruiting
Not Applicable

The Effect of the Timing of Supplemental Parenteral Nutrition on the Prognosis of Critically Ill Patients (T-SPN)

Critical IllnessOrgan DysfunctionEnteral Nutrition Intolerance+1 more
Dong Zhang946 enrolled2 locationsNCT07085455
Recruiting
Not Applicable

Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury

SepsisAcute Gastrointestinal InjuryOrgan Dysfunction Syndrome
Jing Cai, MD116 enrolled1 locationNCT05623722
Recruiting
Not Applicable

Efficacy of SGLT2 Inhibitors in Adults With Sepsis

SepsisInflammationSGLT2-Inhibitors+2 more
Hospital Authority, Hong Kong60 enrolled3 locationsNCT06473844
Recruiting
Not Applicable

Efficacy and Safety of Hemoperfusion With Polymyxin B in Septic Shock Associated With Severe Endotoxemia in Cardiac Surgery Patients (РМХ vs SS)

Multiple Organ Dysfunction With Severe Endotoxemia
Petrovsky National Research Centre of Surgery20 enrolled1 locationNCT04920565
Recruiting
Not Applicable

Validation of Hematological Indices

SepsisPneumoniaWound Infection+1 more
Petrovsky National Research Centre of Surgery200 enrolled1 locationNCT06476171
Recruiting
Not Applicable

Safety and Efficacy of Fecal Microbiota Transplantation

AlopeciaDiabetes MellitusObesity+24 more
Chinese University of Hong Kong450 enrolled1 locationNCT04014413
Recruiting

COVID-19 Outcome Prediction Algorithm

Frailty SyndromeCOVID-19Post Acute Sequelae of COVID-19+2 more
University of California, Los Angeles600 enrolled7 locationsNCT05471011